Transforming growth factor beta s and wound healing

被引:546
作者
OKane, S
Ferguson, MWJ
机构
[1] School of Biological Sciences, 3.239 Stopford Building, University of Manchester
基金
英国惠康基金;
关键词
TGF beta s; wound healing; fibrosis; scarring; chronic wounds;
D O I
10.1016/S1357-2725(96)00120-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Transforming Growth Factor beta superfamily (TGF beta) is one of the most complex groups of cytokine with widespread effects on many aspects of growth and development. The TGF beta isoforms and other family members, e.g. Activins and BMPs, have diverse effects in similar physiological situations. TGF beta is involved in the wound healing process. The three mammalian isoforms (TGF beta 1, 2 and 3) and recently other family members, e.g. Activin, have been localised in healing wounds. Manipulation of the ratios of TGF beta superfamily members, particularly the ratio of TGF beta 1 relative to TGF beta 3, reduces scarring and fibrosis. Such manipulations include reducing the levels of TGF beta 1/TGF beta 2 using neutralising antibodies or preventing the activation of TGF beta s. In chronic or impaired wounds the exogenous addition of TGF beta superfamily members accelerates aspects of the healing process. This review summarises evidence for the role of TGF beta superfamily members in wound healing and how modulation of TGF beta levels can prevent scarring and fibrosis. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:63 / 78
页数:16
相关论文
共 129 条
[1]  
ALEXANDROW MG, 1995, CANCER RES, V55, P1452
[2]  
ASHCROFT GS, 1995, J ANAT, V187, P1
[3]   TRANSFORMING GROWTH-FACTOR-BETA ACTIVATION IN IRRADIATED MARINE MAMMARY-GLAND [J].
BARCELLOSHOFF, MH ;
DERYNCK, R ;
TSANG, MLS ;
WEATHERBEE, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :892-899
[4]  
BARCELLOSHOFF MH, 1995, FASEB J, V9, pA125
[5]   ONE SYSTEMIC ADMINISTRATION OF TRANSFORMING GROWTH-FACTOR-BETA-1 REVERSES AGE-IMPAIRED OR GLUCOCORTICOID-IMPAIRED WOUND-HEALING [J].
BECK, LS ;
DEGUZMAN, L ;
LEE, WP ;
XU, Y ;
SIEGEL, MW ;
AMENTO, EP .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2841-2849
[6]   EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN DYSTROPHIC PATIENT MUSCLES CORRELATES WITH FIBROSIS - PATHOGENETIC ROLE OF A FIBROGENIC CYTOKINE [J].
BERNASCONI, P ;
TORCHIANA, E ;
CONFALONIERI, P ;
BRUGNONI, R ;
BARRESI, R ;
MORA, M ;
CORNELIO, F ;
MORANDI, L ;
MANTEGAZZA, R .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :1137-1144
[7]  
Bodo M, 1995, CELL MOL BIOL, V41, P1039
[8]   TRANSFORMING GROWTH FACTOR-BETA(1) ENHANCES GLOMERULAR COLLAGEN-SYNTHESIS IN DIABETIC RATS [J].
BOLLINENI, JS ;
REDDI, AS .
DIABETES, 1993, 42 (11) :1673-1677
[9]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[10]   The recombinant proregion of transforming growth factor beta 1 (Latency-associated peptide) inhibits active transforming growth factor beta 1 in transgenic mice [J].
Bottinger, EP ;
Factor, VM ;
Tsang, MLS ;
Weatherbee, JA ;
Kopp, JB ;
Qian, SW ;
Wakefield, LM ;
Roberts, AB ;
Thorgeirsson, SS ;
Sporn, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5877-5882